MinatoT., ItoS., LiB., et al.Liquid biopsy with droplet digital PCR targeted to specific mutations in plasma cell-free tumor DNA can detect ovarian cancer recurrence earlier than CA125. Gynecologic Oncology Reports. 38(2021): 100847 (2021).
2.
GalicaJ., GirouxJ., FrancisJ-A., et al.Coping with fear of cancer recurrence among ovarian cancer survivors living in small urban and rural settings: A qualitative descriptive study. European Journal of Oncology Nursing. 44: 101705 (2020).
3.
YasuiH., KobayashiM., SatoK., et al.Circulating cell-free DNA in the peripheral blood plasma of patients is an informative biomarker for multiple myeloma relapse. International Journal of Clinical Oncology. 26: 2142–2150 (2021).
4.
CarissimiF., BarbagliaM.N., Salmi. L., et al.Finding the seed of recurrence: Hepatocellular carcinoma circulating tumor cells and their potential to drive the surgical treatment. World J. Gastrointest. Surg., 13(9): 967–978 (2021).
5.
BarkJ.M., KulasingheA., HartelG., et al.Isolation of circulating tumour cells in patients with glioblastoma using spiral microfluidic technology – a pilot study. Front. Oncol., 11:681130 (2021).
6.
SchusterE., TaftafR., ReduzziC., et al.Better together: circulating tumor cell clustering in metastatic cancer. Trends in Cancer. 7(11):P1020–1032 (2021).
7.
ZhangZ., LeeS.H., CaruanaR., et al.Circulating tumor cell assay enables prediction of recurrence following stereotactic body radiotherapy for early-stage non-small cell lung cancer: an interpretable machine learning study. International J. Radiation Oncology, Biology, Physics., 111,(3), supplement, e123. (2021).
8.
AvanziniS.A., KurtzD.M., ChabonJ.J., et al.A mathematical model of ctDNA shedding predicts tumor detection size. Science Advances. 6(50): eabc4308 (2020).
